TY  - BOOK
AU  - Heba Aly Mohamed Ateya
AU  - Heba Mohamed Elzawahry , 
AU  - Nadia Mahmoud Mokhtar , 
AU  - Osman Mohamed Mansour , 
TI  - The role of neoadjuvant aromatase inhibitors in ER / PR positive  HER-2 neu negative in postmenopausal females with locally advanced breast cancer / 
PY  - 2013///
CY  - Cairo : 
PB  - Heba Aly Mohamed Ateya , 
KW  - Aromatase inhibitors
KW  - locally advanced breast cancer
KW  - Neoadjuvant
N1  - Thesis (Ph.D.) - Cairo University - National Cancer Institute - Department of Oncology (Medical); Issued also as CD
N2  - Background: In Egypt female breast cancer ranks as the first malignancy affecting females (37.5% in NCI Egypt). Approximately 20% to 25% of breast cancer patients present with locally advanced disease. Methods : this is a prospective study including fifty two female postmenopausal patients with newly diagnosed LABC, they receive 4 months of neoadjuvant aromatase inhibitor (letrozole) 2.5 mg daily followed by clinical and radiological evaluation, if they have at least partial response, they will be refered to surgery
UR  - http://172.23.153.220/th.pdf
ER  -